Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. IRWD
IRWD logo

IRWD Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy Ironwood Pharmaceuticals Inc (IRWD) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Hold
Latest Price
4.470
1 Day change
2.05%
52 Week Range
5.780
Analysis Updated At
2026/07/03
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.

IRWD is not a clear buy right now for a beginner long-term investor with $50,000-$100,000 to deploy. The technical setup is constructive, but the stock has just run up and options/insider data do not confirm a strong long-term entry. My direct view is to hold off on buying aggressively and wait for either a pullback or a stronger fundamental catalyst.

Technical Analysis

The short-term trend is bullish: MACD histogram is positive and expanding, and the moving averages are aligned bullishly with SMA_5 > SMA_20 > SMA_200. Price at 4.21 is below the reported current-price reference of 4.33 and sits near the pivot area of 3.962, with resistance at 4.306 and 4.518. RSI_6 at 73.368 indicates the stock is extended rather than early in a fresh move. Overall, momentum is positive, but the move looks stretched for an immediate beginner long-term entry.

Options Data

Neutral
Open Interest Put-Call Ratio
Bullish
Option Volume Put-Call Ratio

Options sentiment is mixed-to-bullish. The open interest put-call ratio of 0.98 is near neutral, while the option volume put-call ratio of 0.04 is strongly call-skewed, suggesting near-term bullish speculation. Implied volatility is elevated at 80.5, and the current option volume is well above average, which signals active trading interest. However, the lack of a stronger directional open-interest advantage means sentiment is supportive but not decisive.

Technical Summary

StrongSellSellNeutralBuyStrongBuydotted line Image
Sell
4
Buy
9

Positive Catalysts

  • ["Bullish moving average alignment suggests the trend is intact.", "Positive and expanding MACD histogram supports upward momentum.", "Options flow shows strong call-heavy short-term trading interest.", "Historical pattern data suggests potential upside over the next week and month.", "Market closed down only slightly in the broader market context, so IRWD\u2019s move stands out relatively."]

Neutral/Negative Catalysts

  • ["Insiders are selling, with selling amount up sharply over the last month.", "No recent news or event-driven catalyst was provided for the past week.", "No recent analyst upgrade or price target support was provided.", "RSI is elevated, indicating the stock may already be overextended.", "Hedge funds are neutral, so institutional conviction is not strong.", "No recent congress trading data is available."]

Financial Performance

No usable latest-quarter financial snapshot was provided because the financial data returned an error. As a result, I cannot confirm recent revenue, earnings, or margin growth trends for the latest quarter season. Based on the available data alone, there is not enough fundamental evidence here to justify a confident long-term buy.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

No analyst rating or price target change data was provided, so there is no visible trend in Wall Street estimates to support a stronger bullish thesis. The Wall Street pros and cons view is therefore incomplete: pros include constructive technical momentum and supportive options activity, while cons include insider selling, no fresh catalysts, and no analyst confirmation.

Wall Street analysts forecast IRWD stock price to rise
3 Analyst Rating
Wall Street analysts forecast IRWD stock price to rise
2 Buy
1 Hold
0 Sell
Moderate Buy
Current: 4.380
sliders
Low
5
Averages
6.23
High
8
Current: 4.380
sliders
Low
5
Averages
6.23
High
8
Citizens
Jason Butler
Outperform
maintain
$8 -> $10
AI Analysis
2026-02-26
Reason
Citizens
Jason Butler
Price Target
$8 -> $10
AI Analysis
2026-02-26
maintain
Outperform
Reason
Citizens analyst Jason Butler raised the firm's price target on Ironwood to $10 from $8 and keeps an Outperform rating on the shares. Ironwood reported Q4 financial results consistent with prior guidance and more importantly reiterated 2026 guidance including adjusted EBITDA of more than $300M, the analyst tells investors in a research note. The firm continues to believe that 2026 guidance supports LINZESS headwinds have passed, and the asset can drive substantial cash flow between now and the loss of brand exclusivity to fund current debt obligations and the apraglutide confirmatory trial/commercial launch.
Craig-Hallum
Hold
to
Buy
upgrade
2026-01-05
Reason
Craig-Hallum
Price Target
2026-01-05
upgrade
Hold
to
Buy
Reason
Craig-Hallum upgraded Ironwood to Buy from Hold with a price target of $5.70, up from $3.80.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for IRWD
Unlock Now

People Also Watch